Federal Circuit Denies Rehearing In Dispute Over Biologics, Patents
WASHINGTON, D.C. — Competing motions for en banc rehearing of a July 2015 ruling by the Federal Circuit U.S. Court of Appeals in a dispute over the Biologics Price Competition and...To view the full article, register now.
Already a subscriber? Click here to view full article